Aptus Capital Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
Aptus Capital Advisors's PJP Position: Q3 2026 in Review
Aptus Capital Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 206 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.
Aptus Capital Advisors first reported a position in PJP in Q3 2022 and has held it in 16 quarters since. 135 funds tracked by Wall St. Rank hold PJP as of Q3 2026.
- Aptus Capital Advisors held 206 shares of Invesco Pharmaceuticals ETF worth $25.4K as of Q3 2026.
- Aptus Capital Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q3 2026, its #1489 holding.
- Aptus Capital Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and has held it in 16 quarters since.
- 135 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.
Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.